B.C. investigates ‘significant’ prescribed drug diversion, including international trafficking
The call for an inquiry into B.C.’s safer supply drug program has intensified after revelations that a significant portion of prescribed opioids is being diverted, with prescribed alternatives being trafficked provincially, nationally, and internationally. The leaked briefing distributed by the Opposition B.C. Conservatives highlights the province’s investigation into the diversion of opioids prescribed by doctors and pharmacists.
Elenore Sturko, the Conservative public safety critic, has been vocal about the potential diversion of prescribed opioids for months and is advocating for a public inquiry into the program. She expressed concern that vulnerable individuals with severe addictions are being exploited for profit by bad actors in pharmacies, housing, and healthcare. Sturko emphasized the need for accountability in the distribution of prescribed alternatives and opioids, suggesting that consumption should be monitored by health professionals.
Health Minister Josie Osborne confirmed the authenticity of the leaked presentation and expressed disappointment over the potential compromise of the investigation. She reassured the public that the government remains focused on addressing the issue, with a special unit comprising former police officers actively conducting the investigation. Osborne underscored the government’s commitment to taking strong action against any bad actors involved in exploiting vulnerable drug users.
The leaked document, although undated, indicates a significant increase in the dispensation of the opioid hydromorphone to treat drug users. It identifies over 60 pharmacies allegedly offering incentives to clients and suggests that some community housing staff mandate tenants to visit specific pharmacies for their prescriptions. The emergence of this information coincides with Canada’s efforts to prevent the trafficking of fentanyl across the border, amidst escalating tensions with the United States.
As the investigation progresses, stakeholders are urged to prioritize the well-being of individuals struggling with substance use disorders and drug addictions. The government’s commitment to connecting individuals with the necessary support underscores the importance of addressing the diversion of prescribed opioids to safeguard public health and safety. In light of these developments, continued vigilance and proactive measures are essential to combat illicit activities within the pharmaceutical sector and protect vulnerable populations from exploitation.
